Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-30

FDA Approved: EURAX — Supplemental Application (Journey Medical Corporation)

View source ↗

Summary

The FDA approved a supplemental application for EURAX (crotamiton) submitted by Journey Medical Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EURAX (Crotamiton)

Snippet

SUPPL AP for EURAX (CROTAMITON)